Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Paris - Delayed Quote EUR

Equasens Société anonyme (EQS.PA)

Compare
33.30
-0.45
(-1.33%)
At close: April 4 at 5:35:13 PM GMT+2
Loading Chart for EQS.PA
  • Previous Close 33.75
  • Open 33.70
  • Bid --
  • Ask --
  • Day's Range 32.70 - 34.05
  • 52 Week Range 32.05 - 67.40
  • Volume 23,365
  • Avg. Volume 16,000
  • Market Cap (intraday) 507.306M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 10.67
  • EPS (TTM) 3.12
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield 1.25 (3.75%)
  • Ex-Dividend Date Jul 2, 2024
  • 1y Target Est 56.65

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

equasens.com

1,271

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EQS.PA

View More

Performance Overview: EQS.PA

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

EQS.PA
24.75%
CAC 40 (^FCHI)
1.43%

1-Year Return

EQS.PA
41.25%
CAC 40 (^FCHI)
10.75%

3-Year Return

EQS.PA
60.97%
CAC 40 (^FCHI)
8.08%

5-Year Return

EQS.PA
36.10%
CAC 40 (^FCHI)
75.11%

Compare To: EQS.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EQS.PA

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    500.54M

  • Enterprise Value

    514.93M

  • Trailing P/E

    10.69

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.28

  • Price/Book (mrq)

    2.28

  • Enterprise Value/Revenue

    2.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.64%

  • Return on Assets (ttm)

    7.74%

  • Return on Equity (ttm)

    20.83%

  • Revenue (ttm)

    215.16M

  • Net Income Avi to Common (ttm)

    42.25M

  • Diluted EPS (ttm)

    3.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    26.21M

  • Total Debt/Equity (mrq)

    23.98%

  • Levered Free Cash Flow (ttm)

    14.12M

Research Analysis: EQS.PA

View More

Company Insights: EQS.PA

Research Reports: EQS.PA

View More

People Also Watch